Iranian
Biomedical Journal
Volume 10, Issue 1 (1-2006)
IBJ 2006, 10(1): 27-32 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alizadeh N, Safa O, Khoramizadeh M R, Pezeshki M. Study of Correlation between Prostate Specific Antigen and Matrix Metalloproteinase-2 Activity in Benign and Malignant Prostate Hyperplasia. IBJ 2006; 10 (1) :27-32
URL: http://ibj.pasteur.ac.ir/article-1-348-en.html
URL: http://ibj.pasteur.ac.ir/article-1-348-en.html
Abstract:
There are emerging data on novel tumor markers such as matrix metalloproteinase-2 (MMP-2 or gelatinase-A), which play a key role in tissue invasion and metastasis. We designed an investigation to assess the usefulness of MMP-2 activity as compared to prostate specific antigen (PSA) in cancer staging process. We have analyzed the circulating form of MMP-2 in serum samples of patients suffering from either benign prostate hyperplasia (BPH, n = 54) or prostate cancer (PC, n = 26), and prostatitis (n = 4) as compared to control normal individual (n = 26), respectively. Protein-content adjusted samples were separated by gelatin-embedded polyacrylamide gel electrophoresis then were subjected to densitometric analysis. Total PSA (tPSA) and free PSA (fPSA) were quantified using a standard ELISA technique. Correlation coefficient (r) between tPSA and MMP-2 activity in patient group was +0.938 and in controls group was 0.799 ( P <0.01). In addition, (r) between tPSA and MMP-2 activity in PC patients was 0.940 and in BPH patients was 0.962 ( P <0.01). (r) between fPSA and MMP2 activity in PC patients was 0.913, in BPH patients was 0.644, and in prostatitis patients was -0.994 (P <0.01). These results demonstrate that MMP-2, compared to PSA, might be considered as a better tumor marker in monitoring and screening patients with PC.
Keywords: Matrix metalloproteinase-2 (MMP-2), Prostate Hyperplasia, Prostate Specific Antigen (PSA), Zymography
Type of Study: Full Length/Original Article |
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |